Annual SG&A
$307.29M$139.93M+83.61%
Summary
- Current Value
- As of today, GRDN annual SG&A is $307.29M, up +83.61% on
- Historical Performance
- GRDN annual SG&A is up +134.37% over the past 3 years, and up +214.97% over the past 5 years
- All-Time High Comparison
- GRDN annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- GRDN annual SG&A is +129.53% above its 3-year low of $133.88M reached on an earlier date
- Sector Comparison
- GRDN annual SG&A is higher than 92.46% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $307.29M | +83.6% | +134.4% | +215.0% | +249.8% | |
| Quarterly SG&A | $58.37M | -64.7% | – | +81.6% | +115.9% | |
| TTM SG&A | $124.72M | -40.5% | – | +36.9% | +361.4% | |
| Price | $30.32 | +50.7% | – | – | – | |
| Annual Operating Expenses | $307.29M | +83.6% | +134.4% | +184.2% | +217.1% | |
| Annual Operating Profit | -$62.92M | -253.7% | -308.7% | -278.1% | -340.8% | |
| Annual D&A | $19.77M | +8.4% | +19.6% | +24.7% | +50.5% | |
| Annual Revenue | $1.23B | +17.4% | +55.1% | +75.9% | +104.6% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $307.29M | at high | |
| 5Y | $307.29M | at high | |
| All | $307.29M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $133.88M | N/A | +129.5% |
| 5Y | $102.54M | N/A | +199.7% |
| All | $87.85M | +249.8% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $307.29M | +83.6% | |
| $167.36M | +25.0% | |
| $133.88M | +2.1% | |
| $131.12M | +27.9% |
| Year | Value | Change |
|---|---|---|
| $102.54M | +5.1% | |
| $97.56M | +11.1% | |
| $87.85M | - |
FAQ
What is the current annual SG&A of GRDN?
As of today, GRDN annual SG&A is $307.29M
What is 1-year change in GRDN annual SG&A?
GRDN annual SG&A is up +83.61% year-over-year
What is 3-year change in GRDN annual SG&A?
GRDN annual SG&A is up +134.37% over the past 3 years
How far is GRDN annual SG&A from its all-time high?
GRDN annual SG&A is currently at its all-time high
How does GRDN annual SG&A rank versus sector peers?
GRDN annual SG&A is higher than 92.46% of companies in Healthcare sector
When is GRDN next annual earnings release?
The next annual earnings release for GRDN is on
Quarterly SG&A
$58.37M$2.80M+5.04%
Summary
- Current Value
- As of today, GRDN quarterly SG&A is $58.37M, up +5.04% on
- Historical Performance
- GRDN quarterly SG&A is down -64.73% year-over-year, with unknown 3-year change
- All-Time High Comparison
- GRDN quarterly SG&A is currently -64.73% below its historical high of $165.49M set on
- 3-Year Low Comparison
- GRDN quarterly SG&A vs 3-year low value is unknown
- Sector Comparison
- GRDN quarterly SG&A is higher than 87.67% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $58.37M | +5.0% | -64.7% | – | +81.6% | |
| Annual SG&A | $307.29M | – | +83.6% | +134.4% | +215.0% | |
| TTM SG&A | $124.72M | -61.4% | -40.5% | – | +36.9% | |
| Price | $30.32 | +28.0% | +50.7% | – | – | |
| Quarterly Operating Expenses | $57.89M | +4.2% | -65.0% | – | +64.7% | |
| Quarterly Operating Profit | $16.83M | +33.8% | +116.1% | – | +10000.0% | |
| Quarterly D&A | $5.84M | +6.4% | +16.9% | +31.0% | – | |
| Quarterly Revenue | $377.43M | +9.6% | +20.1% | – | +107.8% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $58.37M | at high | |
| 3Y | $165.49M | -64.7% | |
| 5Y | $165.49M | -64.7% | |
| All | $165.49M | -64.7% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $50.35M | N/A | +15.9% |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
| Month | Value | Change |
|---|---|---|
| $58.37M | +5.0% | |
| $55.57M | +8.2% | |
| $51.34M | +2.0% | |
| $50.35M | -69.6% | |
| $165.49M | +273.7% |
| Month | Value | Change |
|---|---|---|
| $44.28M | >+9,900.0% | |
| $0.00 | 0.0% | |
| $0.00 | -100.0% | |
| $58.52M | +133.8% | |
| $25.03M | - |
FAQ
What is the current quarterly SG&A of GRDN?
As of today, GRDN quarterly SG&A is $58.37M
What is GRDN quarterly SG&A most recent change?
GRDN quarterly SG&A was up +5.04% on September 30, 2025
What is 1-year change in GRDN quarterly SG&A?
GRDN quarterly SG&A is down -64.73% year-over-year
How far is GRDN quarterly SG&A from its all-time high?
GRDN quarterly SG&A is currently -64.73% below its historical high of $165.49M set on September 30, 2024
How does GRDN quarterly SG&A rank versus sector peers?
GRDN quarterly SG&A is higher than 87.67% of companies in Healthcare sector
When is GRDN next earnings release?
The next earnings release for GRDN is on
TTM SG&A
$124.72M$40.24M+47.63%
Summary
- Current Value
- As of today, GRDN TTM SG&A is $124.72M, up +47.63% on
- Historical Performance
- GRDN TTM SG&A is down -40.55% year-over-year, with unknown 3-year change
- All-Time High Comparison
- GRDN TTM SG&A is currently at its all-time high
- 3-Year Low Comparison
- GRDN TTM SG&A vs 3-year low value is unknown
- Sector Comparison
- GRDN TTM SG&A is higher than 87.37% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $124.72M | -61.4% | -40.5% | – | +36.9% | |
| Annual SG&A | $307.29M | – | +83.6% | +134.4% | +215.0% | |
| Quarterly SG&A | $58.37M | +5.0% | -64.7% | – | +81.6% | |
| Price | $30.32 | +28.0% | +50.7% | – | – | |
| TTM Operating Profit | $59.17M | +195.0% | +192.2% | – | +451.8% | |
| TTM D&A | $21.75M | +4.0% | +12.5% | +156.5% | – | |
| TTM Revenue | $1.39B | +4.8% | +18.7% | – | +152.7% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $124.72M | N/A | at high |
| 3Y | $124.72M | N/A | at high |
| 5Y | $124.72M | N/A | at high |
| All | $124.72M | N/A | at high |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $22.31M | N/A | +459.1% |
| 3Y | $0.00 | N/A | N/A |
| 5Y | $0.00 | N/A | N/A |
| All | $0.00 | N/A | N/A |
TTM SG&A History
| Month | Value | Change |
|---|---|---|
| $215.63M | -33.2% | |
| $322.75M | +3.6% | |
| $311.47M | +19.7% | |
| $260.12M | +24.0% | |
| $209.77M | +104.1% |
| Month | Value | Change |
|---|---|---|
| $102.81M | +23.0% | |
| $83.55M | 0.0% | |
| $83.55M | 0.0% | |
| $83.55M | +233.8% | |
| $25.03M | - |
FAQ
What is the current TTM SG&A of GRDN?
As of today, GRDN TTM SG&A is $124.72M
What is GRDN TTM SG&A most recent change?
GRDN TTM SG&A was up +47.63% on September 30, 2025
What is 1-year change in GRDN TTM SG&A?
GRDN TTM SG&A is down -40.55% year-over-year
How far is GRDN TTM SG&A from its all-time high?
GRDN TTM SG&A is currently at its all-time high
How does GRDN TTM SG&A rank versus sector peers?
GRDN TTM SG&A is higher than 87.37% of companies in Healthcare sector
When is GRDN next earnings release?
The next earnings release for GRDN is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- GRDN Official Website guardianpharmacy.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802255/000119312525274298/0001193125-25-274298-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802255/000119312525064082/0001193125-25-064082-index.htm
- GRDN Profile on Yahoo Finance finance.yahoo.com/quote/GRDN
- GRDN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/grdn